Recent advances in electrospun nanofiber-based implantable drug delivery systems for breast cancer therapy
RSC Pharmaceutics · 2026 · 3 (2) · 276-304
DOI: 10.1039/d5pm00265f ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Jia Xing und 4 weiteren Autor:innen. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 284 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
The review examines electrospun nanofiber implantable systems for targeted breast cancer therapy, emphasizing localized sustained drug release. It classifies studies by drug source and stimulus-response, and outlines clinical translation challenges.
Zitieren
APA
Xing, J., Feng, J., Wang, Q., Yu, D., & Bligh, S. A. (2026). Recent advances in electrospun nanofiber-based implantable drug delivery systems for breast cancer therapy. RSC Pharmaceutics, 3(2), 276-304. https://doi.org/10.1039/d5pm00265f
Vancouver
Xing J, Feng J, Wang Q, Yu D, Bligh SA. Recent advances in electrospun nanofiber-based implantable drug delivery systems for breast cancer therapy. RSC Pharmaceutics. 2026;3(2):276-304. doi:10.1039/d5pm00265f
BibTeX
@article{Xing2026,
author = {Xing, Jia and Feng, Jingjing and Wang, Qilin and Yu, Deng-guang and Bligh, Sim-Wan Annie},
title = {Recent advances in electrospun nanofiber-based implantable drug delivery systems for breast cancer therapy},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {2},
pages = {276--304},
doi = {10.1039/d5pm00265f}
}
EUVIMED